Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Canadian Experience with Fingolimod: Adherence to Treatment and Monitoring.
Depletion of brain functional connectivity enhancement leads to disability progression in multiple sclerosis: A longitudinal resting-state fMRI study.
Medications Are Associated with Falls in People with Multiple Sclerosis: A Prospective Cohort Study.
Isoniazid in autoimmunity: a trigger for multiple sclerosis?
Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome.
Integrating p38α MAPK immune signals in nonimmune cells.
Predictors of chronic cerebrospinal venous insufficiency procedure use among older people with multiple sclerosis: a national case-control study.
Defective Autoimmune Regulator-Dependent Central Tolerance to Myelin Protein Zero Is Linked to Autoimmune Peripheral Neuropathy.
Experimental demyelination and remyelination of murine spinal cord by focal injection of lysolecithin.
Body-worn sensors capture variability, but not decline, of gait and balance measures in multiple sclerosis over 18 months.
Oral Administration of Lactococcus lactis Expressing Synthetic Genes of Myelin Antigens in Decreasing Experimental Autoimmune Encephalomyelitis in Rats.
Central defects of autonomic function in secondary progressive multiple sclerosis: observations based on cardiovascular and growth hormone responses to clonidine.
Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica.
Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
Dissecting the role of E2 protein domains on alphavirus pathogenicity.
[Diagnostic criteria to patients with multiple sclerosis and clinically isolated syndrome].
Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis.
[Epidemiological characteristics of multiple sclerosis in the Kabardino-Balkaria Republic.]
Systemic lupus erythematosus presented as extensive longitudinal myelitis.
A Novel PET Imaging Probe for the Detection and Monitoring of Translocator Protein 18 kDa Expression in Pathological Disorders.
Comment on: 'Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients'
Visibility of lipid resonances in HR-MAS spectra of brain biopsies subject to spinning rate variation.
Central nervous system de- and remyelination is independent from systemic cholesterol level in Theiler's murine encephalomyelitis.
IL-1β Is Involved with the Generation of Pain in Experimental Autoimmune Encephalomyelitis.
Beyond focal cortical lesions in MS: An in vivo quantitative and spatial imaging study at 7T.
Pages
« first
‹ previous
…
582
583
584
585
586
587
588
589
590
…
next ›
last »